Skip to main content

Deeperer editorial

Published

Changed: 17 sections, 24 sources

37 min read

Intermittent Fasting vs Continuous Calorie Restriction for Weight Loss in Adults

Intermittent fasting does not produce meaningfully more weight loss than continuous daily calorie restriction in adults. Across large pooled analyses of randomized trials, the two approaches give about the same loss in people with overweight or obesity. The newest Cochrane review finds little to no difference, at low certainty. Only alternate-day fasting shows an edge, of about 1.3 kg. That edge is below the roughly 2 kg usually treated as clinically relevant, is seen only in trials shorter than 24 weeks, and disappears in longer trials. The common thread is the energy deficit: when fasting arms lose more, they have usually eaten less, and when intake is matched the results converge. Body composition and metabolic markers differ little. Adherence erodes on both approaches over a year. The trials are mostly small, short and unblinded, and evidence beyond 12 months or in healthy-weight adults is thin. Fasting is a reasonable alternative to continuous restriction, not an upgrade on it.

Head-to-head weight loss: no meaningful advantage

Pooled randomized trials put intermittent fasting and continuous calorie restriction at essentially equal weight loss in adults with overweight or obesity.

The 2026 Cochrane review is the newest synthesis. It finds that intermittent fasting "may result in little to no difference in weight loss" compared with traditional dietary advice (21 studies, 1430 people). Its confidence is low because most studies were small and not robustly conducted; it is moderately confident only about fasting compared with no treatment. Two other syntheses agree:

  • A 167-trial network meta-analysis of 11 998 participants found most fasting regimens produced weight loss comparable with continuous restriction at a similar absolute energy restriction.
  • A meta-analysis of longer-term trials concluded the two are comparably effective for weight and adiposity in adults with overweight or obesity.

These three syntheses draw on different trial sets and reach the same answer. That makes equivalence the stable reading, even though Cochrane's certainty is low.1,2,3,4

Throughout, differences are given as fasting minus continuous restriction, so a negative number means more loss on fasting. A 2023 meta-analysis of 28 trials lasting 2-52 weeks pooled time-restricted eating, alternate-day fasting and the 5:2 diet. The combined weight difference was -0.42 kg (95% CI -0.96 to 0.13; P = 0.132). On these inputs, the interval rules out a fasting advantage of more than about 1 kg for fasting diets taken together. The same pooling found slightly greater waist reduction on fasting (-0.91 cm), discussed with body composition below.5

By strategy: only alternate-day fasting shows an edge, and it is small

Alternate-day fasting beats continuous restriction by about 1.3 kg in pooled analyses. The other strategies do not:

  • Time-restricted eating means eating only within a daily window.
  • Whole-day fasting covers 5:2-type schedules with full fasting days each week.

The largest network meta-analysis compared each diet with ad-libitum (unrestricted) eating. Alternate-day fasting gave -3.40 kg (high certainty), whole-day fasting -2.36 kg (high certainty), continuous restriction -2.11 kg (moderate certainty) and time-restricted eating -1.72 kg (moderate certainty). Against continuous restriction directly, only alternate-day fasting added loss: -1.29 kg (95% CI -1.99 to -0.59), at moderate certainty. Time-restricted eating and whole-day fasting did not differ from each other.6

Mean difference in body weight vs ad-libitum eating (kg) by diet

The alternate-day fasting edge falls below the clinical-relevance level. The review's authors say the -1.29 kg comparison "fell below this level", suggesting limited clinical impact. The accompanying BMJ editorial gives that threshold as at least 2 kg for people with obesity. Our calculation: 1.29 kg is about 65% of 2 kg. Even the far end of the confidence interval, -1.99 kg, does not reach the threshold.7,8

An umbrella review of meta-analyses points the same way. Its high-quality associations comparing fasting (alternate-day, time-restricted, whole-day) with continuous restriction show no significant effect on weight or BMI. Moderate-quality associations show small advantages for whole-day or modified alternate-day fasting:

  • -0.55 kg (95% CI -1.01 to -0.09)
  • -1.37 kg (95% CI -2.24 to -0.49)
  • -0.95 kg (95% CI -1.63 to -0.27)

Read together, these suggest at most a small effect.9,10,11

Most 12-month head-to-head trials are null. The one exception ran in an unusual setting.

Trial (12 months)AdultsResult, fasting vs continuous restrictionWhat it means
Time-restricted eating (8 h) plus calorie restriction vs calorie restriction alone139 with obesity-8.0 kg vs -6.3 kg; net -1.8 kg (95% CI -4.0 to 0.4; P=0.11)Null; interval too wide to prove equivalence
Alternate-day fasting vs daily calorie restriction100 metabolically healthy with obesity6.0% vs 5.3% loss relative to control; not significantly differentNull
4:3 intermittent fasting vs daily calorie restriction165 with overweight or obesityMean difference 2.89 kg (95% CI 5.65 to 0.14 kg; P = 0.040) in favour of 4:3Modest benefit, inside an intensive programme

12,13,14

The time-restricted eating trial was designed to detect a 2.5 kg difference. Its interval neither confirms nor excludes a benefit of that size, so it is a null result rather than proof of equivalence. Its intervals were not adjusted for multiple comparisons. Its authors concluded that time-restricted eating was not more beneficial than daily calorie restriction for weight, body fat or metabolic risk factors.15,16,17

In the 4:3 trial, the fasting group cut intake by 80% on 3 nonconsecutive days a week. The comparison group cut daily intake by 34% to match the weekly deficit. Both groups also had a high-intensity behavioural programme, with a target of 300 minutes of activity a week. The authors call the gain modest and note limited generalizability. With a lower bound of 0.14 kg, a single trial in this setting does not overturn the pooled equivalence.18,19

Energy deficit, not meal timing, drives the result

Where fasting arms lose more, they usually also ate less. With intake matched, weight loss is similar. The 167-trial network meta-analysis concludes that in adults with overweight, obesity or metabolic abnormalities, effectiveness "mainly depends on the extent of the energy restriction, regardless of the mealtime patterns."20

Unmatched intake tilts trials toward fasting. In the 2023 meta-analysis, every study that reported a difference in intake found a larger deficit in the fasting arm, sometimes a large one. On these inputs, that bias favours fasting, yet the pooled weight difference stayed non-significant.21

A trial in type 2 diabetes shows the same pattern. Its time-restricted arm ate freely within an 8-hour window, without counting calories. Its comparison arm cut intake by 25% of baseline needs. Yet the time-restricted arm achieved the larger deficit: -313 kcal/d against -197 kcal/d. Its numerically greater loss therefore reflects intake, not timing.22,23,24

When deficits were similar, outcomes converged:

  • In the 1-year alternate-day fasting trial, the fasting arm restricted energy by 21% and the continuous arm by 24% over six months, with no significant difference, and weight loss did not differ.
  • In a trial with overall restriction matched at 33% in both arms, both lost about 12.5% of body weight.25,26,27

A review limited to trials with matched energy intakes found similar weight loss and risk-factor effects for fasting and daily restriction. It judged hints of better fat loss and insulin sensitivity on fasting too limited to support conclusions. A 2025 meta-analysis of isocaloric trials reached the same verdict: fasting "may be an effective alternative to CR but is not superior."28,29

Duration and maintenance: any edge fades with time

In trials of 24 weeks or more, no fasting strategy outperforms continuous restriction. The largest network meta-analysis split trials by length:

  • In the 76 trials under 24 weeks, alternate-day fasting beat continuous restriction by -1.29 kg (95% CI -2.05 to -0.53).
  • In the 17 trials of 24 weeks or more, there were no differences between fasting strategies and continuous restriction.30

Whether fasting is worse at keeping weight off is unsettled. The 167-trial analysis found in a subgroup analysis that weight loss on fasting, but not on continuous restriction, rebounded after 12 weeks. Individual trials do not show this:

  • In the alternate-day fasting trial, regain from month 6 to 12 did not differ between arms (-0.8%; 95% CI -3.2% to 1.7%).
  • In a type 2 diabetes trial, both arms held their 3-month loss at 12 months: 0.4 kg regained on continuous restriction, -0.2 kg on intermittent restriction (P = .48).31,32,33

The longest follow-up is from a randomized trial in adults with overweight or obesity. At week 102, weight change was -4.3% on intermittent calorie restriction and -5.0% on continuous restriction, which was not significantly different. Weight at that point was self-reported by telephone, although earlier self-reports matched measured weights. Between week 50 and week 102, 71.1% of the intermittent group had not continued or only rarely continued their diet, against 32.5% of the continuous group.34,35,36

Long-term evidence is scarce. Only five trials in the largest network meta-analysis reached 52 weeks or more. Cochrane's included studies ran up to 12 months. The 2023 meta-analysis included no trial longer than a year.37,38,39

Populations: a small pooled edge in diabetes, little evidence in healthy-weight adults

In prediabetes or type 2 diabetes, a pooled advantage for fasting appears, but individual diabetes trials are not significant. A 2024 meta-analysis found fasting reduced weight by -1.14 kg (95% CI -1.69 to -0.60) and BMI by -0.43 kg/m² compared with calorie restriction. It did not change fat mass, HbA1c, lipids or blood pressure.40

Two diabetes trials both point to roughly 1.8 units more loss on fasting, without significance:

  • Intermittent energy restriction, 12 months: the weight difference was -1.8 kg (90% CI -3.7 to 0.07). Weight loss was "similar" but failed the equivalence test. HbA1c fell similarly (-0.5% vs -0.3%) and met equivalence.
  • Time-restricted eating, 6 months: the authors summarise this trial as finding time-restricted eating "more effective" (-3.6% vs -1.8%), but both figures are relative to controls. The direct difference was -1.78% of body weight (95% CI -4.09 to 0.53), not significant against the Bonferroni threshold of P < .017.

Both trials are consistent with the small pooled edge.41,42,43,44

The largest network meta-analysis ran a sensitivity analysis in 11 type 2 diabetes trials. Against ad-libitum eating, alternate-day fasting gave a moderate reduction (-4.42 kg), whole-day fasting -2.74 kg, continuous restriction -2.87 kg and time-restricted eating -1.93 kg.45

Most of the evidence comes from people with overweight or obesity. That analysis pooled 6582 participants with a median BMI of 31.3, of whom 720 were healthy and 5862 had existing conditions. Single trials often exclude important groups: the 12-month time-restricted eating trial cannot be generalized to people with diabetes or cardiovascular disease, or to other ethnic groups.46,47

Secondary outcomes: small body-composition differences, similar metabolic markers

Fasting may trim waist and fat mass slightly more than continuous restriction, but it also removes slightly more fat-free (lean) mass. Glucose, insulin, lipids and blood pressure largely do not differ.

MeasureFasting vs continuous restrictionWhat it means
Waist, alternate-day fasting-1.19 cm (95% CI -2.13 to -0.24), moderate certaintySlight extra waist reduction
BMI, alternate-day fasting-0.52 (95% CI -0.85 to -0.19), moderate certaintyMirrors the small weight edge
Fat mass, trials of all lengths-0.31 kg (95% CI -0.98 to 0.36), not significantNo difference overall
Fat mass, time-restricted eating subgroup-0.91 kg (95% CI -1.63 to -0.18; k = 4)Small, few trials
Fat mass, longer-term trials in overweight/obesity-0.70 kg; body fat -0.59%Small advantage in one pooled set
Fat-free mass-0.20 kg (95% CI -0.39 to -0.01)Slightly more lean loss on fasting
Fasting glucose-0.01 mmol/L (95% CI -0.08 to 0.05)No difference
Fasting insulin-0.17 μIU/mL (95% CI -0.82 to 0.47)No difference
HOMA-IR (insulin resistance), alternate-day fasting-0.73 (95% CI -1.43 to -0.03; k = 4)One small subgroup benefit
Triglycerides, total, HDL and LDL cholesterolAll non-significantNo difference
Blood pressureSystolic -0.48 mm Hg, diastolic -0.67 mm Hg, not significant; diastolic -0.91 mmHg and HDL +0.03 mmol/l in longer-term trialsMostly no difference

48,49,50,51,52,53

Fat-mass advantages are inconsistent. They appear in some pooled sets but not in the 1-year alternate-day fasting trial. That trial found no differences in fat mass, lean mass or visceral fat at 6 or 12 months.54

That trial also found no differences in blood pressure, glucose, insulin or triglycerides. However, LDL cholesterol was 11.5 mg/dL (95% CI 1.9-21.1 mg/dL) higher at month 12 on alternate-day fasting than on daily restriction. HDL cholesterol rose at 6 months but not at 12.55

One umbrella-review association covering 1438 adults with overweight or obesity found fasting less effective at lowering systolic pressure (SMD = 0.21; 95% CI 0.05-0.36).56

A pooling of isocaloric trials found fasting cut fat mass and IL-6 (an inflammation marker) in the short term. In the long term it improved body fat percentage, waist, fasting insulin and HOMA-IR. On the other side, continuous restriction brought significantly lower hunger, fatigue and triglycerides.57

Adherence and dropout: no advantage for fasting

Adherence falls on both approaches over a year. Fasting arms show equal or higher dropout.

TrialFasting armContinuous restriction armWhat it means
Alternate-day fasting, 1 year, dropout13 of 34 (38%)10 of 35 (29%); control 26%Highest dropout on fasting
Intermittent energy restriction in type 2 diabetes, 12 months, dropout19 (27.1%)21 (31.3%); P = .71Similar
Same diabetes trial, compliance97% in first 3 months, then 44%90%, then 49%Both decline sharply
Whole-day fasting trial in the largest network meta-analysis, adherence74% at 6 weeks, 22% at 52 weeksNot givenSteep long-run decline
Time-restricted eating in type 2 diabetes, 6 monthsEating window kept on 87% of days68% of participants met calorie goalsFasting reported as easier

58,59,60,61,62

Most trials in the largest network meta-analysis report high adherence of over 80%. However, most of its 52-week trials described poor adherence in the intervention groups.

In the 1-year alternate-day fasting trial, more continuous-restriction participants met their energy goals at months 3, 6, 9 and 12. Fasting participants ate more than prescribed on fast days and less than prescribed on feast days. On this evidence, fasting schedules can be harder to follow precisely, even where some people find them simpler.63,64

How far to trust the evidence

The finding that the two approaches are equivalent holds across syntheses, but individual estimates are imprecise. The largest network meta-analysis judged more than 80% of its trials at low risk of bias. Even so, it downgraded certainty for several reasons:

  • Heterogeneity: unexplained differences between trial results.
  • Incoherence: direct and indirect comparisons disagreeing.
  • Imprecision from small samples.
  • Indirectness: only three trials compared fasting strategies with each other directly.

Its median follow-up was 12 weeks, with a range of 3-52 weeks.65,66,67

Judgements of bias differ between reviews, and the difference matters. The 2023 meta-analysis rated 82.8% of its trials as having some bias concerns. This was mainly because trials did not report whether outcome assessors knew the participants' diet. Participants always knew their arm, since every study involved an energy-restricted diet. A 2021 umbrella review rated most associations at very serious risk of bias, partly because masking is impossible when two diets are compared. It also noted a median trial size of 38 participants, a median follow-up of 3 months, and significant findings resting mostly on very low to low quality evidence. The low-bias rating should therefore be read as "no serious flaws beyond the unavoidable", not as blinded-trial quality.68,69,70

What the sources gathered do not establish

  • Whether the comparison holds in healthy-weight adults. There is no separate estimate for them, so advice for people not trying to treat overweight rests on extrapolation.
  • Whether intermittent fasting helps or hinders keeping weight off beyond 12 months. Few trials reach 52 weeks, and the 102-week data are self-reported. This is the question that matters most for long-term choice.
  • The pooled difference in weight loss as a percentage of body weight. The syntheses report kilograms only, which makes it harder to compare results across people of different sizes.
  • Exactly how each regimen and its comparator were defined in the largest network meta-analysis. That bears on whether its alternate-day fasting edge reflects calorie-matched arms or a larger deficit.
  • Whether the short-term alternate-day fasting advantage persists when energy intake is strictly matched. If it does not, the one strategy-specific edge would be explained entirely by eating less.

Sources (70)

  1. 1
    www.cochrane.org
    Compared to traditional dietary advice, intermittent fasting may result in little to no difference in weight loss, measured as change from starting weight (21 studies, 1430 people) and quality of life (three studies, 106 people). We are not sure about its effect on achieving a 5% reduction in body weight (4 studies, 472 people) or on unwanted events (7 studies, 619 people).
  2. 2
    www.cochrane.org
    We are moderately confident in the results for weight loss when comparing intermittent fasting with no treatment. However, our confidence is low to very low for our other points of interest because most included studies did not use the most robust methods, they included few people, and reported results that were inconclusive.
  3. 3
    pubmed.ncbi.nlm.nih.gov
    Results: The study included 167 eligible trials with a total enrollment of 11 998 participants. Most IF diet regimens induced significant weight loss that was comparable with that induced by CER diet regimens with a similar absolute energy restriction, based on low- to high-certainty evidence.
  4. 4
    pubmed.ncbi.nlm.nih.gov
    Subgroup analyses showed that the mode of IF and intervention duration were the primary moderators of IF effects on the markers. In adults with overweight or obesity, IF and CR are comparably effective for reducing body weight and adiposity, as well as for improving cardiometabolic health markers.
  5. 5
    europepmc.org
    Twenty-eight trials were identified that studied TRE (k = 7), ADF (k = 10), or the 5:2 diet (k = 11) for 2-52 wk. Energy intakes between intervention groups within a study were comparable (17 trials), lower in IER (5 trials), or not reported (6 trials). Weighted mean differences (WMDs) were calculated using fixed- or random-effects models. Changes in body weight [WMD: -0.42 kg; 95% confidence interval (CI): -0.96 to 0.13; P = 0.132] and fat mass (FM) (WMD: -0.31 kg; 95% CI: -0.98 to 0.36; P = 0.362) were comparable when results of the 3 IER diets were combined and compared with those of CER. All IER diets combined reduced fat-free mass (WMD: -0.20 kg; 95% CI: -0.39 to -0.01; P = 0.044) and waist circumference (WMD: -0.91 cm; 95% CI: -1.76 to -0.06; P = 0.036) more than CER. Effects on body mass index [BMI (kg/m 2 )], glucose, insulin, homeostatic model assessment for insulin resistance (HOMA-IR), serum lipid and lipoprotein concentrations, and blood pressure did not differ. Further, TRE reduced body weight, FM, and fat-free mass more than CER, whereas ADF improved HOMA-IR more. BMI was reduced less in the 5:2 diet compared with CER. In conclusion, the 3 IER diets combined did not lead to superior improvements in anthropometrics and cardiometabolic risk markers compared with CER diets. Slightly greater reductions were, however, observed in fat-free mass and waist circumference. To what extent differences in energy intakes between groups within studies may have influenced these outcomes should be addressed in future studies.
  6. 6
    web.archive.org
    When compared with the ad-libitum diet, the network analysis showed a small reduction in body weight for ADF (mean difference -3.40 kg (95% CI -4.14 to -2.67), high certainty of evidence), WDF (-2.36 kg (-3. 02 to -1.70), high certainty of evidence), and CER (-2.11 kg (-2.73 to -1.50), moderate certainty of evidence); while TRE showed a trivial reduction (-1.72 kg (-2.21 to -1.22), moderate certainty of evidence) (fig 3). Furthermore, the ADF diet resulted in a trivial additional weight loss when compared with CER (-1.29 kg (-1.99 to -0.59), moderate certainty of evidence). Comparisons between intermittent fasting diet strategies showed a trivial reduction in body weight for ADF versus both TRE (-1.69 kg (-2.49 to -0.88) and WDF -1.05 kg (-1.90 to -0.19), both moderate certainty of evidence); however, no difference was noted between the TRE and WDF diet comparison (fig 3).
  7. 7
    web.archive.org
    While many observed reductions with intermittent fasting strategies compared to ad-libitum exceeded this threshold, individual strategies of intermittent fasting particularly ADF versus CER (-1.29 kg) fell below this level, suggesting somewhat limited clinical impact in those comparisons.
  8. 8
    web.archive.org
    The results show that all strategies produced significant weight reductions compared with ad libitum diets. Alternate day fasting was the only intervention with additional reductions in body weight (-1.29 kg), body mass index, and certain lipid parameters compared with continuous energy restriction, although with small effects and moderate certainty according to GRADE.4 Importantly, these differences did not reach the prespecified clinical relevance threshold of at least 2 kg defined for individuals with obesity.
  9. 9
    europepmc.org
    Six associations conducted on participants with overweight or obesity, type 2 diabetes (T2DM) patients, metabolic syndrome, and premenopausal women, compared IF (MADF, TRE, TWF, and ADF) with CER diets, reporting no significant effects with high quality evidence on weight and BMI 14 , 16 , 18 , 45
  10. 10
    europepmc.org
    Schwinghackl et al., 2020 53 Body weight TWF, MADF/CER 13 MD -0.55 (-1.01, -0.09) 0.019 0.0 Moderate High Schwinghackl et al., 2020 53 Body weight TWF/CER 9 MD -1.37 (-2.24, -0.49) 0.002 0.0 Moderate High
  11. 11
    europepmc.org
    He et al., 2021 62 Body weight MADF, TWF/CER 11 MD -0.95 (-1.63, -0.27) 0.006 21.3 Moderate High
  12. 12
    web.archive.org
    Of the total 139 participants who underwent randomization, 118 (84.9%) completed the 12-month follow-up visit. The mean weight loss from baseline at 12 months was -8.0 kg (95% confidence interval [CI], -9.6 to -6.4) in the time-restriction group and -6.3 kg (95% CI, -7.8 to -4.7) in the daily-calorie-restriction group. Changes in weight were not significantly different in the two groups at the 12-month assessment (net difference, -1.8 kg; 95% CI, -4.0 to 0.4; P=0.11). Results of analyses of waist circumferences, BMI, body fat, body lean mass, blood pressure, and metabolic risk factors were consistent with the results of the primary outcome. In addition, there were no substantial differences between the groups in the numbers of adverse events.
  13. 13
    web.archive.org
    Findings This randomized clinical trial included 100 metabolically healthy obese adults. Weight loss after 1 year in the alternate-day fasting group (6.0%) was not significantly different from that of the daily calorie restriction group (5.3%), relative to the no-intervention control group. Meaning Alternate-day fasting does not produce superior weight loss or weight maintenance compared with daily calorie restriction.
  14. 14
    www.ovid.com
    Results: Of the 165 (4:3 IMF, n = 84; DCR, n = 81) randomly assigned participants (mean age, 42 years [SD, 9]; mean BMI, 34.1 kg/m 2 [SD, 4.4]; 73.9% female), 125 completed the trial. In an intention-to-treat analysis, 4:3 IMF showed greater reductions in weight than DCR at 12 months (mean difference, 2.89 kg [95% CI, 5.65 to 0.14 kg]; P = 0.040).
  15. 15
    web.archive.org
    Assuming an anticipated dropout rate of 20%, we estimated that an enrollment target of 138 participants (69 per group) would provide the trial with greater than 90% statistical power to detect a significant difference of 2.5 kg in body weight (±2.4) between the time-restricted-eating group and the daily-calorie-restriction group at a significance level of 0.025 using a two-tailed test.
  16. 16
    web.archive.org
    The 95% confidence intervals are not adjusted for multiple comparisons and should not be used to infer definitive treatment effects.
  17. 17
    web.archive.org
    Among patients with obesity, a regimen of time-restricted eating was not more beneficial with regard to reduction in body weight, body fat, or metabolic risk factors than daily calorie restriction.
  18. 18
    www.ovid.com
    Design: Randomized clinical trial. (ClinicalTrials.gov: NCT03411356) Setting: Denver, Colorado, and surrounding metropolitan area. Participants: Adults aged 18 to 60 years with body mass index (BMI) of 27 to 46 kg/m 2 . Intervention: The IMF group was instructed to restrict energy intake by 80% on 3 nonconsecutive days per week, with ad libitum intake (no restriction) the other 4 days (4:3 IMF). The DCR group was instructed to reduce daily energy intake by 34% to match the weekly energy deficit of 4:3 IMF. Both groups received a high-intensity comprehensive behavioral weight loss program that included group-based behavioral support and a recommendation to increase moderate-intensity physical activity to 300 minutes per week. Measurements: The primary outcome was change in body weight (in kilograms) at 12 months.
  19. 19
    www.ovid.com
    Limitation: Limited generalizability. Conclusion: Compared with DCR, 4:3 IMF resulted in modestly greater weight loss among adults with overweight or obesity enrolled in a 12-month, high-intensity, comprehensive behavioral weight loss program.
  20. 20
    pubmed.ncbi.nlm.nih.gov
    In adults with overweight, obesity, or metabolic abnormalities, effectiveness in weight loss mainly depends on the extent of the energy restriction, regardless of the mealtime patterns.
  21. 21
    europepmc.org
    When interpreting the results, it is important to realize that decreases in energy intake during the intervention periods between the IER and CER groups were not comparable in all included studies, which makes it difficult to compare the specific diets without the influence of differences in energy intake. All studies that reported a significant difference in energy intakes between the IER and CER groups found a greater caloric deficit over the intervention period in the IER group. For some studies, this difference in energy deficit between groups was relatively large, and we therefore expected to find a greater effect size for body weight than the meta-analysis found. In addition, subgroup analyses showed that body weight and FFM were more reduced in the IER diet than in the CER diet in the 2 subgroups with and without a comparable decrease in energy intake between the 2 arms. These effects did not differ between subgroups with and without a comparable decrease in energy intake.
  22. 22
    web.archive.org
    Participants in the TRE group ate ad libitum between 12:00 and 8:00 pm daily and fasted from 8:00 pm to 12:00 pm the following day. During the 8-hour eating window, participants were not required to monitor caloric intake, and there were no restrictions on types or quantities of food consumed.
  23. 23
    web.archive.org
    Participants in the CR group were instructed to reduce their energy intake by 25% of their baseline energy needs every day.
  24. 24
    web.archive.org
    The mean (SD) caloric deficit was -313 (509) kcal/d for the TRE group, -197 (426) kcal/d for the CR group, and -16 (439) kcal/d for the control group over 6 months.
  25. 25
    web.archive.org
    From baseline to month 6, the alternate-day fasting group achieved a mean (SD) percentage energy restriction of 21% (16%), and the daily calorie restriction group achieved a mean (SD) percentage energy restriction of 24% (16%), with no significant difference between the intervention groups or compared with the control group (eFigure 2 in Supplement 2).
  26. 26
    europepmc.org
    Macronutrient composition and overall energy restriction (33% reduction) were similar between groups.
  27. 27
    europepmc.org
    Changes in body weight (≈12.5% WL) and composition were similar in both groups.
  28. 28
    pubmed.ncbi.nlm.nih.gov
    Conclusions: With matched energy intakes, IF interventions produced similar beneficial effects for weight loss and chronic disease risk factors compared with DCR. Very limited evidence suggests that IF may be more effective vs DCR for fat loss and insulin sensitivity, but conclusions cannot be drawn based on the current evidence.
  29. 29
    www.sciencedirect.com
    IF may be an effective alternative to CR but is not superior to CR in enhancing human health. Due to the low number of long-term studies, future studies should focus on conducting longitudinal randomized trials comparing IF and CR in different populations, age groups, and IF patterns.
  30. 30
    web.archive.org
    The network analysis by trial duration for body weight is shown in fig 4. In trials with less than 24 weeks of follow-up (n=76), ADF showed a small body weight reduction compared with ad-libitum (mean difference -3.37 kg (95% CI -4.16 to -2.59)), and a trivial reduction in weight compared with CER (-1.29 kg (-2.05 to -0.53)), and TRE (-1.72 kg (-2.58 to -0.87)). Compared with ad-libitum, both WDF and CER showed a small reduction in body weight and TRE showed a trivial reduction in weight. Additionally, WDF showed a trivial reduction in body weight when compared with TRE (-0.88 kg (-1.71 to -0.06)). In trials of 24 weeks or more (n=17), the most restrictive strategies (ADF, TRE, and CER) showed small body weight reductions versus ad-libitum (mean difference range -1.88 to -3.63 kg), with no differences between intermittent fasting strategies and CER in these moderate-to-long term studies. WDF, however, showed a trivial reduction in weight loss when compared with ad-libitum.
  31. 31
    pubmed.ncbi.nlm.nih.gov
    Similar results were noticed for body measurements, blood pressure, blood lipids, and glycemic profiles. In the subgroup analysis, the weight-loss effects of the IF but not the CER diet regimens experienced rebound after 12 weeks.
  32. 32
    web.archive.org
    Weight regain from months 6 to 12 (-0.8%; 95% CI, -3.2% to 1.7%) was not significantly different between the alternate-day fasting group and the daily calorie restriction group.
  33. 33
    europepmc.org
    Both groups lost significant weight between baseline and 3 months, which was maintained at 12 months (mean [SEM] weight reduction from 3 to 12 months was 0.4 [0.5] kg in the continuous energy restriction group and -0.2 [0.6] kg in the intermittent energy restriction group; P = .48).
  34. 34
    europepmc.org
    Weight change at wk102 after baseline was slightly, but not significantly lower with ICR than CCR (-4.3% ± 1.0% vs. -5.0% ± 1.1%).
  35. 35
    europepmc.org
    When asked whether they had continued with the diets initially assigned to them between the end of the active study (wk50) and the telephone follow-up (wk102), 71.1% of the participants in the ICR group reported that they had not at all or only rarely done so, compared to 32.5% in the CCR group ( p < 0.001, Table S6 ).
  36. 36
    europepmc.org
    Importantly, weight at wk102 was assessed by telephone interview. However, weight values at wks 4 to 10, which were also based on self-reports via telephone, were plausible compared to measured values at wks 0 and 12, indicating accuracy of self-reported weight at wk102 ( Figure S3 ).
  37. 37
    web.archive.org
    A small subset of trials had a duration of three weeks, the minimum threshold, typically reporting modest weight reductions (eg, 0.5-2 kg), consistent with early phase feasibility studies. Conversely, only five trials extended to 52 weeks or more, limiting the feasibility of undertaking a robust analysis for very long term outcomes. Of the intermittent fasting diet groups, we identified 38 studies that evaluated WDF, 40 studies that evaluated TRE, and 25 studies that evaluated ADF.
  38. 38
    www.cochrane.org
    The included studies focused on short-term effects of the intervention (up to 12 months), limiting the applicability of the evidence in this review to inform decision-making for longer durations. It would be beneficial for future studies to extend follow-up periods beyond 12 months to build a stronger evidence base for the long-term effects.
  39. 39
    europepmc.org
    Furthermore, no RCTs with a duration of >1 y were included, making it difficult to comment on the long-term health effects of these types of diets.
  40. 40
    europepmc.org
    Furthermore, IF decreased body weight (WMD -1.14 kg [95% CI -1.69 to -0.60]; p = 0.001) and BMI (WMD -0.43 kg.m 2 [95% CI -0.58 to -0.27]; p = 0.001), but did not significantly affect fat mass, lean body mass, visceral fat, insulin, HbA1c, lipid profiles or blood pressure.
  41. 41
    europepmc.org
    Intention-to-treat analysis showed similar reductions in mean (SEM) HbA1c level between the continuous and intermittent energy restriction groups (-0.5% [0.2%] vs -0.3% [0.1%]; P = .65), with a between-group difference of 0.2% (90% CI, -0.2% to 0.5%) meeting the criteria for equivalence. Mean (SEM) weight change was similar between the continuous and intermittent energy restriction groups (-5.0 [0.8] kg vs -6.8 [0.8] kg; P = .25), but the between-group difference did not meet the criteria for equivalence (-1.8 kg; 90% CI, -3.7 to 0.07 kg), nor did the between-group difference in fat mass (-1.3 kg; 90% CI, -2.8 to 0.2 kg) or fat-free mass (-0.5 kg; 90% CI, -1.4 to 0.4 kg).
  42. 42
    web.archive.org
    In a 6-month randomized clinical trial involving 75 adults with T2D, TRE was more effective for weight loss (-3.6%) than CR (-1.8%) compared with controls. However, changes in HbA 1c levels did not differ between the TRE (-0.91%) and CR (-0.94%) groups compared with controls.
  43. 43
    web.archive.org
    Variable No. of participants Participant group, mean change from baseline (95% CI) Mean difference between groups (95% CI) Baseline 6 mo TRE CR Control TRE vs CR TRE vs control CR vs control Weight Body weight, % lost 75 68 -4.28 (-6.26 to -2.31) -2.50 (-3.83 to -1.18) -0.72 (-2.14 to 0.69) -1.78 (-4.09 to 0.53) -3.56 (-5.92 to -1.20) b -1.78 (-3.67 to 0.11) Body weight, kg 75 68 -4.52 (-6.73 to -2.30) -2.63 (-3.99 to -1.27) -1.07 (-2.70 to 0.57) -1.89 (-4.42 to 0.64) -3.45 (-6.13 to -0.77) b -1.56 (-3.63 to 0.51)
  44. 44
    web.archive.org
    A Bonferroni-adjusted 2-tailed P < .017 was considered statistically significant for pairwise group comparisons of percentage change in body weight.
  45. 45
    web.archive.org
    We conducted a sensitivity network meta-analyses for studies with people with type 2 diabetes (n=11) (supplementary figure 35). Briefly, TRF compared with ad-libitum only showed a trivial improvement for body weight (mean difference -1.93 kg (95% CI -2.44 to -1.43)), while WDF (-2.74 kg (-4.30 to -1.18)) and CER (-2.87 kg (-4.63 to -1.11)) diets showed small reductions in body weight compared with ad-libitum. ADF, however, showed a moderate reduction in body weight compared with ad-libitum (-4.42 kg (-5.91 to -2.94)). Additionally, TRE showed a moderate reduction for BMI, small reductions for fasting blood glucose and waist circumference, and trivial reductions for both fasting plasma insulin and HOMA-IR. WDF, however, only showed a moderate improvement for fasting plasma insulin when compared with ad-libitum. Among intermittent fasting strategies, ADF moderately improved body weight reduction compared with both TRE, while TRE resulted in a moderate increase in fasting plasma insulin compared with WDF.
  46. 46
    web.archive.org
    Overall, included participants had a median age of 45 years (interquartile range 36-50), had overweight or obesity (median BMI of 31.3 (interquartile range 28.4-33.3)), and were mostly female (66% female, 34% male) (total n=6582). The participants had varying health conditions, including having overweight or obesity (54 studies), type 1 diabetes or type 2 diabetes (12 studies), metabolic syndrome (8 studies), or metabolic dysfunction-associated fatty liver disease (also known as nonalcoholic fatty liver disease; 8 studies); overall, 720 individuals were healthy and 5862 had existing health conditions.
  47. 47
    web.archive.org
    Our trial also has certain limitations. First, our findings could not be generalized to patients with diabetes or cardiovascular disease, to different periods of time-restricted eating, or to persons of other races or ethnic groups. Second, total energy expenditure was not assessed in this trial. Energy expenditure as measured by the double-labeled water method would have helped to explain differences among patients in weight loss in response to the diet interventions. Third, physical activity was not controlled in this trial because we aimed to examine the effects of diet regimens on weight loss in isolation.
  48. 48
    web.archive.org
    Similar beneficial results in body weight were observed for intermittent fasting strategies with ad-libitum diets for other body measurements including BMI, body fat, and waist circumference. Among these measurements, ADF showed a large reduction in BMI when compared with ad-libitum (mean difference -1.22 (95% CI -1.55 to -0.89), high certainty of evidence); however, reductions in waist circumference were small (high certainty of evidence) and in body fat were trivial (moderate certainty of evidence). Additionally, moderate reductions in BMI were observed in ADF with WDF (-0.53 (-0.94 to -0.13)) and TRE (-0.60 (-0.97 to -0.24)), with moderate certainty of evidence (fig 5, supplementary figure 4). Furthermore, ADF showed reductions in both BMI (-0.52 (-0.85 to -0.19)) and waist circumference (-1.19 cm (-2.13 to -0.24)), when compared with CER, both with moderate certainty of evidence.
  49. 49
    europepmc.org
    Relevant heterogeneity between studies was found for body weight, BMI, and WC ( I 2 > 50%). FFM decreased more in the IER diet groups than in the CER diet group (WMD: -0.20 kg; 95% CI: -0.39 to -0.01; k = 16; P = 0.044, Supplementary Figure 1D ) and no relevant heterogeneity was observed ( I 2 = 39.7%). No overall effect was found for FM (WMD: -0.31 kg; 95% CI: -0.98 to 0.36; k = 15; P = 0.362; Supplementary Figure 1E ), and heterogeneity was relevant ( I 2 = 74.9%). The changes in FFM and FM were significantly greater for TRE than that for CER (FFM: WMD: -0.34 kg; 95% CI: -0.67 to -0.01; k = 5; P = 0.042 | FM: WMD: -0.91 kg; 95% CI: -1.63 to -0.18; k = 4; P = 0.014). These significant subgroup effects were not observed for ADF and the 5:2 diet.
  50. 50
    pubmed.ncbi.nlm.nih.gov
    Compared with CR, IF significantly reduced fat mass [WMD: -0.70 kg], body fat percentage [WMD: -0.59%], and DBP [WMD: -0.91 mmHg], and increased HDL [WMD: 0.03 mmol/l], with no other significant effects.
  51. 51
    europepmc.org
    Changes in fasting TG (WMD: -0.01 mmol/L; 95% CI: -0.07 to 0.04; k = 17; P = 0.673; Supplementary Figure 2A ), TC (WMD: -0.03 mmol/L; 95% CI: -0.11 to 0.05; k = 16; P = 0.604; Supplementary Figure 2B ), HDL cholesterol (WMD: -0.001 mmol/L; 95% CI: -0.03 to 0.02; k = 16; P = 0.934; Supplementary Figure 2C ), and LDL cholesterol concentrations (WMD: -0.04 mmol/L; 95% CI: -0.10 to 0.02; k = 16; P = 0.162, Supplementary Figure 2D ) were not significantly different between IER and CER.
  52. 52
    europepmc.org
    Comparable changes were observed between IER and CER for fasting glucose concentrations (WMD: -0.01 mmol/L; 95% CI: -0.08 to 0.05; k = 19; P = 0.681; Supplementary Figure 3A ), fasting insulin concentrations (WMD: -0.17 μIU/mL; 95% CI: -0.82 to 0.47; k = 14; P = 0.604; Supplementary Figure 3B ) and HOMA-IR (WMD: -0.07; 95% CI: -0.22 to 0.08; k = 13; P = 0.338; Supplementary Figure 3C ). No heterogeneity was present for these outcomes ( I 2 < 50%). When analyzed separately, TRE, ADF, and the 5:2 diet did not show significantly different changes in glucose and insulin concentrations compared with the CER diet, whereas HOMA-IR decreased more in ADF than in CER (WMD: -0.73; 95% CI: -1.43 to -0.03; k = 4; P = 0.042).
  53. 53
    europepmc.org
    Changes in SBP and DBP did not significantly differ between IER and CER (SBP: WMD: -0.48 mm Hg; 95% CI: -1.64 to 0.69; k = 15; P = 0.423 | DBP: WMD: -0.67 mm Hg; 95% CI: -2.05 to 0.71; k = 14; P = 0.342; Supplementary Figure 4 ). Relevant heterogeneity was found for DBP ( I 2 = 59.2%) and not for SBP. In agreement with the overall effects of SBP and DBP, none of the separate IER diets differed significantly from the CER diet ( P > 0.05).
  54. 54
    web.archive.org
    There were no statistically significant differences between the alternate-day fasting group and the daily calorie restriction group for fat mass, lean mass, or visceral fat mass at month 6 or month 12.
  55. 55
    web.archive.org
    There were no significant differences between the intervention groups in blood pressure, heart rate, triglycerides, fasting glucose, fasting insulin, insulin resistance, C-reactive protein, or homocysteine concentrations at month 6 or 12. Mean high-density lipoprotein cholesterol levels at month 6 significantly increased among the participants in the alternate-day fasting group (6.2 mg/dL [95% CI, 0.1-12.4 mg/dL]), but not at month 12 (1.0 mg/dL [95% CI, -5.9 to 7.8 mg/dL]), relative to those in the daily calorie restriction group. Mean low-density lipoprotein cholesterol levels were significantly elevated by month 12 among the participants in the alternate-day fasting group (11.5 mg/dL [95% CI, 1.9-21.1 mg/dL]) compared with those in the daily calorie restriction group.
  56. 56
    europepmc.org
    It is worth noting that one associations of SBP, which recruited 1438 participants with overweight or obesity (SMD = 0.21; 95% CI: 0.05-0.36; p = 0.008), found that IF was less effective at lowering SBP than CER.
  57. 57
    www.sciencedirect.com
    IF groups had significant reductions in fat mass (kg) (P=0.006) and Interleukin-6 (P<0.00001) in the short term and fat mass (%) (P=0.0002), waist circumference (P=0.005), fasting blood insulin (P<0.00001) and HOMA-IR (P=0.04) in the long term. CR groups had significantly lower hunger (P=0.003), fatigue (P=0.04), and TG (P=0.03).
  58. 58
    web.archive.org
    Among the 100 participants (86 women and 14 men; mean [SD] age, 44 [11] years), the dropout rate was highest in the alternate-day fasting group (13 of 34 [38%]), vs the daily calorie restriction group (10 of 35 [29%]) and control group (8 of 31 [26%]).
  59. 59
    europepmc.org
    Ninety-seven participants (70.8%) completed the study ( Figure 1 ), and the dropout rates were similar in both groups (21 participants [31.3%] in the continuous energy restriction group and 19 participants [27.1%] in the intermittent energy restriction group; P = .71).
  60. 60
    europepmc.org
    Overall compliance to both diets was excellent during the first 3 months of treatment (90% in the continuous energy restriction group and 97% in the intermittent energy restriction group; P = .21), after which the compliance rates decreased in both groups (49% in the continuous energy restriction group and 44% in the intermittent energy restriction group; P = .62).
  61. 61
    web.archive.org
    Of the 99 identified studies, 74 studies included description of adherence or sufficient information to determine adherence. Most trials reported high adherence (>80%) throughout the duration of the study. Among the trials that had a 52 week follow-up,50 57 59 64 79 most stated poor adherence in the intervention groups. In one study,59 adherence to the WDF declined from 74% at six weeks to 22% at 52 weeks.
  62. 62
    web.archive.org
    The TRE group reported being adherent with their eating window a mean (SD) of 6.1 (0.8) days per week (87% of days) over 6 months (eFigure 2 in Supplement 2). In the CR group, 17 participants (68%) reported being adherent with their prescribed calorie goals during the 6-month trial (eFigure 2 in Supplement 2). Participants in the TRE group reported finding their diet intervention easier to adhere to compared with CR group participants (eFigure 3 in Supplement 2).
  63. 63
    web.archive.org
    A higher proportion of participants in the daily calorie restriction group were adherent to their energy goals at months 3, 6, 9, and 12 relative to those in the alternate-day fasting group.
  64. 64
    web.archive.org
    Participants in the alternate-day fasting group ate more than prescribed on fast days, and less than prescribed on feast days, while those in the daily calorie restriction group generally met their prescribed energy goals.
  65. 65
    web.archive.org
    Conversely, important limitations should be considered. Firstly, the GRADE evaluation of the certainty of evidence was downgraded due to considerable heterogeneity and incoherence in the primary outcome of body weight among the various diet strategy comparisons. These downgrades are reflective of unexplained inconsistencies in the treatment effects (heterogeneity) and variations in the direct versus indirect estimates (incoherence). Certainty of evidence was also downgraded for imprecision based on 95% CIs crossing the prespecified minimal important differences for the outcomes of interest. Many randomised clinical trials had small sample sizes, which would have influenced the precision of the effect estimates. Similar downgrades were applied for several secondary cardiometabolic risk factors. Secondly, evidence of serious concern was considered for indirectness in several analyses, particularly among intermittent fasting strategy comparisons. Only three randomised clinical trials of direct assessment between intermittent fasting diets were available, thereby limiting generalisability and resulting in downgrades for indirectness.
  66. 66
    web.archive.org
    Taken together with the evidence of the present literature, a serious risk of bias was not indicated because more than 80% of studies were considered to have low risk of bias.
  67. 67
    web.archive.org
    Of the identified randomised clinical trials, almost all (92%) were parallel in study design, with a median follow-up time of 12 weeks (range 3-52 weeks)
  68. 68
    europepmc.org
    In total, 5 studies (17.2%) were classified as having a low RoB, whereas the other studies (82.8%) were classified as having some bias concerns. This was mainly because most of these studies did not report whether outcome assessors were aware of the intervention received by the participants. Furthermore, all studies involved energy-restricted diets, and hence, participants were aware of their assigned intervention arm.
  69. 69
    web.archive.org
    Most associations were rated as very serious in the domain of risk of bias in the individual studies according to the GRADE criteria. Associations were finally rated as high risk of bias partly because of the lack of masking participants and personnel, which could have influenced treatment allocation and outcome measurement between groups. Understandably, masking could not be appropriately performed in RCTs of IF since 2 different dietary strategies were compared.
  70. 70
    web.archive.org
    Findings A total of 11 meta-analyses comprising 130 RCTs (median [IQR] sample size, 38 [24-69] participants; median [IQR] follow-up period, 3 [2-5] months) were included describing 104 unique associations of different types of IF with obesity-related health outcomes (median [IQR] studies per association, 4 [3-5]). There were 28 statistically significant associations (27%) that demonstrated the beneficial outcomes for body mass index, body weight, fat mass, low-density lipoprotein cholesterol, total cholesterol, triglycerides, fasting plasma glucose, fasting insulin, homeostatic model assessment of insulin resistance, and blood pressure. IF was found to be associated with reduced fat-free mass. One significant association (1%) supported by high-quality evidence was modified alternate-day fasting for 1 to 2 months, which was associated with moderate reduction in body mass index in healthy adults and adults with overweight, obesity, or nonalcoholic fatty liver disease compared with regular diet. Six associations (6%) were supported by moderate quality evidence. The remaining associations found to be significant were supported by very low (75 associations [72%]) to low (22 associations [21%]) quality evidence.

Made with Deeperer. Editorial-grade research, cited inline

Ask your own question. Get a report like this one.

Start a report

More reports

Cite as: Deeperer. "Intermittent Fasting vs Continuous Calorie Restriction for Weight Loss in Adults." Deeperer, 2 Nov 2026. https://deeperer.com/r/intermittent-fasting-vs-continuous-calorie-restriction-4

Produced by AI from the cited sources. Check it against them before you act on it.